Korean J Pathol.
2000 Apr;34(4):273-279.
Epidermal Growth Factor Receptor Expression and Cell Proliferation in Renal Cell Carcinoma
- Affiliations
-
- 1Department of Pathology, College of Medicine, Seonam University, Namwon 590-711, Korea.
- 2Department of Pathology, Chonnam University Medical School.
Abstract
-
The epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein whose
expression is a possible cause of increased tumor cell proliferation and has recently been proposed
as a prognostic parameter in some tumors. Expression of EGFR was studied
immunohistochemically in 62 cases of human renal cell carcinomas to evaluate their possible
prognostic roles. We also examined the correlation between EGFR expression and cell proliferation
by immunohistochemical staining for proliferating cell nuclear antigen (PCNA). Fifty-six cases
(90.3%) expressed EGFR, with staining largely confined to the cell membrane and cytoplasm.
Staining intensity of EGFR was directly correlated with nuclear grade (p=0.000) and TNM stage
(p=0.015). PCNA index was significantly higher in EGFR-positive tumors than in EGFR- negative
tumors. There was a statistically significant positive correlation between PCNA index and
increasing staining intensity of EGFR (p=0.000). In univariate survival analysis, EGFR expression
was significantly associated with shortened survival. However, EGFR expression was not an
independent prognostic factor by multivariate analysis. These findings suggest that EGFR
expression may be an important cause of tumor cell proliferation in renal cell carcinoma and
further studies are needed to evaluate whether EGFR expression analysis provides independent
prognostic information.